10% Off All Tests - Spring 2025
Pravastatin is one of the older statins, first patented in 1980 and approved for medical use in 1989 (15). Despite its age, it remains widely prescribed and well-studied. Pravastatin is a hydrophilic statin, meaning it has an affinity for water and tends to stay in the bloodstream, rather than penetrating deeply into body tissues like the liver, muscles, or brain. This property is believed to reduce the risk of side effects—particularly muscle-related symptoms—compared to more lipophilic statins.
When prescribing or taking pravastatin, it’s important to consider not only its cholesterol-lowering ability but also its broader effects on heart health—and the timing of when it’s taken. Like other statins, pravastatin offers pleiotropic benefits that go beyond reducing LDL cholesterol (2, 3, 4, 7).
A growing body of research shows that statins reduce the risk of death in people with a variety of heart conditions—including heart failure and cardiovascular disease—and can even limit the extent of heart damage after a heart attack. Remarkably, many of these benefits are independent of cholesterol levels, thanks to the pleiotropic effects of statins. These include (2, 3, 4, 7):
Stabilising cholesterol plaques (atherosclerotic plaques), reducing the risk of rupture and clot formation by lowering inflammation, oxidative stress, and immune activation.
Improving blood vessel function by supporting healthy dilation and lowering blood viscosity, which leads to better circulation.
Cholesterol production in the liver follows a daily rhythm, peaking between 8 p.m. and midnight—up to four times higher than in the morning (12).
Because of this, taking statins like pravastatin in the evening—especially if they are short-acting—can enhance their effectiveness in lowering cholesterol levels.
Explore Cardiovascular PGxStatins like pravastatin may be prescribed for several reasons (5):
High cholesterol levels that haven’t responded well to lifestyle changes such as a healthy diet and increased physical activity
Primary prevention of heart attacks and strokes in people at high cardiovascular risk
Secondary prevention of cardiovascular events—such as after a heart attack or stroke. While this is a common use of pravastatin, it may be considered off-label in some regions. Nonetheless, it is strongly supported by clinical evidence.
How and when to take it
Pravastatin is typically taken once daily at night, which aligns with the body’s natural rhythm of cholesterol production. Doses are adjusted every 4 weeks based on your response (5).
For High Cholesterol:
For Cardiovascular Prevention:
Pravastatin is generally well tolerated and widely prescribed. However, like all medications, it can cause side effects in some individuals. Being aware of both common and less common side effects can help you monitor your response to treatment and know when to seek advice.
Pravastatin is a hydrophilic statin, meaning it stays mostly in the bloodstream and penetrates less into tissues such as muscle and brain. This doesn’t affect its ability to lower cholesterol or inflammation, but it does reduce the likelihood of side effects, especially muscle-related symptoms (3, 6).
Muscle symptoms are the most commonly reported side effects of statins (5, 6, 7), including:
Pain, soreness, or tenderness not linked to physical activity or infection
Most often affecting the thighs, calves, or hip flexors
Usually symmetrical
Occurring in 10–29% of patients
The leading reason for stopping statin therapy
If you experience unexplained muscle discomfort, speak with your pharmacist or GP. These may be early signs of statin-associated muscle symptoms (SAMS) and are best addressed early.
Some people are more likely to experience muscle symptoms while on statins. Risk factors include (11):
Age over 60
Diabetes
Hypothyroidism
Multisystem diseases
Vitamin D deficiency
Strenuous physical activity
Alcohol use
Major surgery
Higher statin doses — the strongest known risk factor (6x increase)
If you have myasthenia gravis and notice worsening symptoms while taking pravastatin, speak with your GP. Although rare, statins have been reported to aggravate this condition and should be reviewed promptly (5).
There are growing reports of memory issues associated with statin use, particularly at higher doses. While clinical evidence is mixed, if you’ve recently started or increased your dose and notice memory lapses, poor concentration, or low mood, it’s a good idea to speak with a healthcare professional (8, 9).
In addition to muscle symptoms, pravastatin may cause other less common side effects (5), including:
Joint pain
Fatigue or lack of energy
Dizziness
Sleep disturbances
Liver enzyme changes
Memory problems
As one of the most hydrophilic statins, pravastatin remains largely in the bloodstream and penetrates tissues like muscle, liver, and brain to a lesser extent. This likely explains why it’s associated with fewer side effects—particularly muscle-related ones—compared to more lipophilic statins. If you're concerned about side effects, a pharmacogenomics (PGx) test in the UK can help identify how your genes influence your response to pravastatin and other statins.
Pravastatin’s journey through the body—how it’s absorbed, distributed, metabolised, and eliminated—is shaped by both biology and genetics. These areas of study, known as pharmacokinetics and pharmacogenetics, help explain why people may respond differently to the same medication (10).
Pravastatin has an oral bioavailability of approximately 18%. The estimated liver extraction rate—based on absorption and bioavailability—is around 47%, meaning a substantial portion is taken up by the liver after absorption.
Pravastatin is transported into the liver and intestines by the OATP1B1 and OATP2B1 transporters. These proteins help move the drug into the right tissues where it can be most effective.
Unlike many other statins, pravastatin undergoes minimal liver metabolism. It is primarily eliminated unchanged in the bile and urine, with around 64% of intravenous doses excreted as intact drug. The main excretion route is via the bile, supported by transporter proteins such as MRP2, BSEP, and BCRP. Its elimination half-life is approximately 1.8 hours, making it one of the shorter-acting statins.
Your genes can significantly influence how well pravastatin works—and whether you experience side effects.
One of the most important genes is SLCO1B1, which encodes the OATP1B1 transporter (10, 11):
OATP1B1 helps move pravastatin into liver cells, where it lowers cholesterol.
Reduced function of this transporter—caused by common gene variants—can lead to higher levels of statins in the bloodstream, increasing the risk of muscle-related side effects.
These pharmacogenetic insights also apply to other commonly prescribed statins, including:
Explore Cardiovascular PGx1. https://pmc.ncbi.nlm.nih.gov/articles/PMC3108295/ 2. https://pmc.ncbi.nlm.nih.gov/articles/PMC11660731/ 3. https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2021.687585/full 4. https://pmc.ncbi.nlm.nih.gov/articles/PMC2694580/ 5. BNF – British National Formulary 2025: https://www.nice.org.uk/about/what-we-do/evidence-and-best-practice-resources/british-national-formulary--bn 6. https://pubmed.ncbi.nlm.nih.gov/39681285/ 7. https://www.mdpi.com/1999-4923/16/2/214 8. https://pmc.ncbi.nlm.nih.gov/articles/PMC5830056/ 9. https://pmc.ncbi.nlm.nih.gov/articles/PMC5005588/ 10. https://www.sciencedirect.com/science/article/pii/S2405844025000088 11. https://pubmed.ncbi.nlm.nih.gov/35152405/ 12. https://www.jlr.org/article/S0022-2275(20)32008-3/fulltext 13. https://www.ncbi.nlm.nih.gov/books/NBK532919/ 14. https://pmc.ncbi.nlm.nih.gov/articles/PMC3303484/ 15. https://pmc.ncbi.nlm.nih.gov/articles/PMC10506175/ 16. https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2012.00335/ful 17. https://pmc.ncbi.nlm.nih.gov/articles/PMC4408357/